ELOCTATE (Biogen Inc.)
Welcome to the PulseAid listing for the ELOCTATE drug offered from Biogen Inc.. This pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
| LABELER NAME / MANUFACTURER: | Biogen Inc. |
| NON-PROPRIETARY NAME: | Antihemophilic Factor (Recombinant), Fc Fusion Protein |
| SUBSTANCE NAME: | |
| TYPE: | PLASMA DERIVATIVE |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-07-14 |
| END MARKETING DATE: | 0000-00-00 |
ELOCTATE PLASMA DERIVATIVE Details:
| Item Description | ELOCTATE from Biogen Inc. |
| LABELER NAME: | Biogen Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2014-07-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 64406-806_d25b3c7e-cc02-4988-ace5-b238e42bd458 |
| PRODUCT NDC: | 64406-806 |
| APPLICATION NUMBER: | BLA125487 |